SCHEMBL6633698

SCHEMBL6633698

Cn1cnc(S(=O)(=O)N(c2ccc(OC(=O)N3CCN(c4ccccn4)CC3)cc2)[C@@](C)(C(=O)O)C(=O)[C@H]2NC(C)(C)CS2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 10/20 0.38
TSHR P16473 8/20 0.38
ALDH1A1 P00352 8/20 0.38
CYP3A4 P08684 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
MAPK1 P28482 3/20 0.38
CYP2D6 P10635 2/20 0.35
KDM4E B2RXH2 6/20 0.34
LMNA P02545 4/20 0.34
ADRB2 P07550 1/20 0.34
GPR119 Q8TDV5 1/20 0.33
HPGD P15428 2/20 0.33
ATM Q13315 1/20 0.32
MAPT P10636 1/20 0.32
TRPA1 O75762 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635754 0.81 LMNA (0.37) HSD17B10TSHRALDH1A1CYP3A4SMN1; SMN2
SCHEMBL6632073 0.81 HSD17B10 (0.42) HSD17B10TSHRALDH1A1CYP3A4SMN1; SMN2
SCHEMBL3853158 0.80 P2RX7 (0.39) HSD17B10TSHRALDH1A1CYP3A4SMN1; SMN2
SCHEMBL6632031 0.80 BCHE (0.37) HSD17B10TSHRALDH1A1CYP3A4SMN1; SMN2
SCHEMBL6636006 0.77 OXTR (0.32) ALDH1A1KMT2A
SCHEMBL6637256 0.76 NPY2R (0.38) ALDH1A1CYP1A2CYP2C9CYP2C19MAPK1
SCHEMBL6636303 0.73 KDM4E (0.34) HSD17B10TSHRALDH1A1SMN1; SMN2CYP1A2
SCHEMBL3851899 0.70 P2RX7 (0.38) HSD17B10TSHRALDH1A1CYP3A4SMN1; SMN2
SCHEMBL6633881 0.70 ALDH1A1 (0.42) TSHRALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL3850149 0.69 HSD17B10 (0.42) HSD17B10TSHRALDH1A1CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000051-B1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2004-05-19 EP claimed